Neridronic Acid
- Generic Name
- Neridronic Acid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H17NO7P2
- CAS Number
- 79778-41-9
- Unique Ingredient Identifier
- 8U27U3RIN4
- Associated Conditions
- Algodystrophy, Osteogenesis Imperfecta (OI), Paget’s Disease
- Associated Therapies
- -
Safety of Intravenous Neridronic Acid in CRPS
- First Posted Date
- 2016-11-23
- Last Posted Date
- 2019-11-21
- Lead Sponsor
- Grünenthal GmbH
- Target Recruit Count
- 580
- Registration Number
- NCT02972359
- Locations
- 🇺🇸
US004: Northwestern University - Feinberg School of Medicine - Rehabilitation Institute of Chicago (RIC), Chicago, Illinois, United States
🇺🇸US033: Alliance Research Centers, Laguna Hills, California, United States
🇺🇸US005: International Clinical Research Institute, Overland Park, Kansas, United States
Efficacy Study of Neridronate to Treat Painful Osteoarthritis of the Knee With Bone Marrow Lesions.
- First Posted Date
- 2013-03-04
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- ASST Gaetano Pini-CTO
- Target Recruit Count
- 60
- Registration Number
- NCT01803360
- Locations
- 🇮🇹
Istituto Ortopedico Gaetano Pini, Milano, MI, Italy
Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI
- Conditions
- Interventions
- First Posted Date
- 2010-06-09
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Ente Ospedaliero Ospedali Galliera
- Target Recruit Count
- 120
- Registration Number
- NCT01140321
- Locations
- 🇮🇹
Centro della Microcitemia e delle Anemie Congenite - Ematologia E.O. Ospedali Galliera, Genova, Italy
🇮🇹Divisione di Ematologia, Ospedale "Perrino", Brindisi, Italy
🇮🇹Dipartimento di Medicina Clinica e Sperimentale, Sezione di Pediatria, Università di Ferrara, Ferrara, Italy
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.